Rising rates of appendiceal cancer, commonly known as appendix cancer, among younger adults have drawn increased attention from medical researchers. Data from the United States show that appendiceal tumor cases among adults aged 29 to 44 increased by 71% over a 10-year period. Concurrently, UK findings indicate that the incidence of appendix cancer multiplied fivefold between 1995 and 2016, with the sharpest increase recorded in the 20 to 39 age cohort.
Diagnostic Shifts and Tumor Reclassification
While appendix cancer remains rare—maintaining an incidence of about 1.6 cases per 100,000 people in the UK—clinicians are investigating the drivers behind the upward trajectory. Part of the rising case count stems from changes in diagnostic practices and pathology protocols. An increase in routine or incidental appendectomies has led to the discovery of more hidden tumors. Post-2000 World Health Organization guidelines reclassified certain low-risk or benign-appearing carcinoid tumors as neuroendocrine tumors (NETs), incorporating them directly into official cancer registries.
Professor Aziz, head of the appendix cancer center at The Christie hospital in Manchester, notes that pathologists now examine surgical appendix specimens much more thoroughly than in the past. This rigorous microscopic screening identifies more early-stage neuroendocrine tumors that typically require no further treatment beyond the initial appendectomy. However, changes in detection do not account for every observed rise.
Growth in Aggressive Subtypes
Data show that more aggressive forms of the disease have also become more common. Invasive appendiceal adenocarcinoma cases have increased approximately threefold since 1995, while pseudomyxoma peritonei (PMP)—a rare peritoneal malignancy typically triggered by a ruptured appendiceal tumor—has risen by roughly 2.5 times. These advanced malignancies are frequently diagnosed at later stages, requiring complex surgical and medical interventions.
Medical researchers continue to study potential risk factors, pointing to genetic predispositions, gut microbiome imbalances, obesity, physical inactivity, and diets high in ultra-processed foods as areas requiring further investigation.
Patient Experience and Late-Stage Diagnosis
Early-stage appendix cancer often presents with vague or non-specific symptoms, such as mild abdominal pain or persistent bloating, leading many patients to overlook the warning signs. Jonathan Pearcey, a UK resident diagnosed with PMP at age 40, experienced prolonged abdominal bloating and discomfort before a computerized tomography (CT) scan performed during a hernia procedure revealed the malignancy. In 2024, Pearcey underwent a 12.5-hour cytoreductive surgery involving the removal of his spleen, gallbladder, appendix, and major portions of his large intestine, followed by chemotherapy. His case highlights the challenges of detecting appendiceal malignancies before they progress.
Keep reading